Attilio Orazi

发表

Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.

D. Heilman, M. Albitar, R. Neiman, 2000, American journal of clinical pathology.

Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).

N. Fineberg, N. Heerema, F. Smith, 2000, American journal of clinical pathology.

013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.

R. Neiman, P. B. Robertson, A. Orazi, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow.

G. Sledge, R. Hoffman, M. Kahsai, 1996, Experimental hematology.

In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsies.

G. Sledge, M. Gordon, K. John, 1995, American Journal of Clinical Pathology.

Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections.

G. Cattoretti, J. Manning, R. Neiman, 1994, American journal of clinical pathology.

Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.

N. Heerema, G. Cattoretti, G. Sozzi, 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment.

G. Cattoretti, R. Luksch, D. Soligo, 1993, Leukemia.

p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.

M. Kahsai, R. Neiman, A. Orazi, 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.

G. Parmiani, C. Gambacorti-Passerini, R. Molinari, 1990, Cancer research.

Preliminary Studies on Melatonin in the Treatment of Myelodysplastic Syndromes Following Cancer Chemotherapy

A. Santoro, G. Sozzi, F. Fraschini, 1990, Journal of pineal research.

Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer.

G. Sledge, H. Broxmeyer, M. Gordon, 1998, Blood cells, molecules & diseases.

Molecular Epidemiology of EBNA-1 Substrains of Epstein-Barr Virus in Posttransplant Lymphoproliferative Disorders Which Have Infrequent p53 Mutations

A. Abou-Elella, A. Orazi, J. Anderson, 2000, Leukemia & lymphoma.